Profitability
Net margin −4.1% (FY26)
Median of the other 5: 12.5%
BSE: CSURGSU · Healthcare · Medical Equipment & Supplies · Market cap ₹34 Cr
· Prev close ₹97.50 · Volume 62
Company profile: not in our data yet
Net margin −4.1% (FY26)
Median of the other 5: 12.5%
Generated Return on capital is 5.0%, 6th of 6 listed peers; Amkay Products is first at 13.5%.
Profit, last 4 quarters vs the 4 before: not in our data yet
Generated In FY26 revenue was +0.6% on FY25.
P/E not shown: the EPS for the 4 quarters Sep 2025 to Jun 2026 is a loss
Generated The other 3 listed peers have a median P/E of 16.7×.
Of profit came in as cash, last 5 fiscal years: not in our data yet
Generated Operating cash was positive in each of the two years FY25–26; FY26 alone brought in ₹4 cr. Total debt was ₹11 cr at the end of FY26, against a net worth of ₹29 cr.
Held by domestic funds: not in our data yet
In 1 month: not in our data yet
Generated The close is below its 20-day average of ₹96.
An earnings call transcript: not in our data yet
Scored statements from the earnings calls: none yet.
Earnings outlook Generated
In Q1 FY27 (Jun 26), net profit was +1,980.0% on the year-earlier quarter; operating margin was 14.3% against 9.5%.
An earnings call transcript: not in our data yet